Miriam Elbracht

Prof. Dr. Miriam Elbracht

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 July 2024 in Nature Genetics
Verified
Journal Article
Open access
PDF file
ASAxel Schmidt
Axel Schmidt
MDMagdalena Danyel
Magdalena Danyel
KGKathrin Grundmann
Kathrin Grundmann
TBTheresa Brunet
Theresa Brunet
HKHannah Klinkhammer
Hannah Klinkhammer
MWMatias Wagner
Matias Wagner
Individuals with ultrarare disorders pose a structural challenge for healthcare systems since expert clinical knowledge is required to establish diagnoses. In TRANSLATE NAMSE, a 3-year prospective study, we evaluated a novel diagnostic concept based on multidisciplinary expertise in Germany. Here we present the systematic investigation of the phenotypic and molecular genetic data of 1,577 patients who had undergone exome sequencing and were partially analyzed with next-generation phenotyping approaches. Molecular genetic diagnoses were established in 32% of the patients totaling 370 distinct molecular genetic causes, most with prevalence below 1:50,000. During the diagnostic process, 34 novel and 23 candidate genotype–phenotype associations were identified, mainly in individuals with neurodevelopmental disorders. Sequencing data of the subcohort that consented to computer-assisted analysis of their facial images with GestaltMatcher could be prioritized more efficiently compared with approaches based solely on clinical features and molecular scores. Our study demonstrates the synergy of using next-generation sequencing and phenotyping for diagnosing ultrarare diseases in routine healthcare and discovering novel etiologies by multidisciplinary teams.

27 February 2007 in Journal of Medical Genetics
Verified
Journal Article
Closed access
PDF file
Miriam ElbrachtMiriam Elbracht
Miriam Elbracht
JSJan Senderek
Jan Senderek
TEThomas Eggermann
Thomas Eggermann
CTChristian Thürmer
Christian Thürmer
JPJonas Park
Jonas Park
KZKlaus Zerres
Klaus Zerres
Mutations in the transmembrane protease, serine 3 (TMPRSS3) gene, encoding a transmembrane serine protease, cause autosomal recessive deafness childhood (DFNB8) or congenital onset (DFNB10). TMPRSS3 mutations have been mainly identified in patients from Asian and Mediterranean countries and seem to be a rare finding in the Northern European population so far. The identification of two novel pathogenic TMPRSS3 mutations (c.646C→T − R216C; c.916G→A − A306T) is described in four affected siblings of German origin with postlingual hearing loss, treated by bilateral cochlear implantation with good results. Although TMPRSS3 mutations are supposed to be a rare cause of autosomal recessive hearing loss, in families with postlingual disease onset TMPRSS3 is the most favourable candidate gene after exclusion of GJB2 mutations.

1 November 2024 in Science
Verified
Journal Article
Closed access
FKFlorian Kraft
Florian Kraft
PRPiere Rodriguez-Aliaga
Piere Rodriguez-Aliaga
WYWeimin Yuan
Weimin Yuan
LFLena Franken
Lena Franken
KZKamil Zajt
Kamil Zajt
IKIngo Kurth
Ingo Kurth
Malformations of the brain are common and vary in severity, from negligible to potentially fatal. Their causes have not been fully elucidated. Here, we report pathogenic variants in the core protein-folding machinery TRiC/CCT in individuals with brain malformations, intellectual disability, and seizures. The chaperonin TRiC is an obligate hetero-oligomer, and we identify variants in seven of its eight subunits, all of which impair function or assembly through different mechanisms. Transcriptome and proteome analyses of patient-derived fibroblasts demonstrate the various consequences of TRiC impairment. The results reveal an unexpected and potentially widespread role for protein folding in the development of the central nervous system and define a disease spectrum of “TRiCopathies.”

22 February 2018 in Clinical Genetics
Verified
Journal Article
Closed access
PDF file
GGG. Gillessen‐Kaesbach
G. Gillessen‐Kaesbach
BAB. Albrecht
B. Albrecht
TEThomas Eggermann
Thomas Eggermann
Miriam ElbrachtMiriam Elbracht
Miriam Elbracht
DMD. Mitter
D. Mitter
JBJ. Beygo
J. Beygo

22 January 2021 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
PDF file
RMRobert Meyer
Robert Meyer
MBMatthias Begemann
Matthias Begemann
CHChristian Thomas Hübner
Christian Thomas Hübner
DDDaniela Dey
Daniela Dey
AKAlma Kuechler
Alma Kuechler
TEThomas Eggermann
Thomas Eggermann
Background: Silver-Russell syndrome (SRS) is an imprinting disorder which is characterised by severe primordial growth retardation, relative macrocephaly and a typical facial gestalt. The clinical heterogeneity of SRS is reflected by a broad spectrum of molecular changes with hypomethylation in 11p15 and maternal uniparental disomy of chromosome 7 (upd(7)mat) as the most frequent findings. Monogenetic causes are rare, but a clinical overlap with numerous other disorders has been reported. However, a comprehensive overview on the contribution of mutations in differential diagnostic genes to phenotypes reminiscent to SRS is missing due to the lack of appropriate tests. With the implementation of next generation sequencing (NGS) tools this limitation can now be circumvented. Main body: We analysed 75 patients referred for molecular testing for SRS by a NGS-based multigene panel, whole exome sequencing (WES), and trio-based WES. In 21/75 patients a disease-causing variant could be identified among them variants in known SRS genes (IGF2, PLAG1, HMGA2). Several patients carried variants in genes which have not yet been considered as differential diagnoses of SRS. Conclusions: WES approaches significantly increase the diagnostic yield in patients referred for SRS testing. Several of the identified monogenetic disorders have a major impact on clinical management and genetic counseling.

15 June 2021 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
ELEva Lausberg
Eva Lausberg
SGSebastian Gießelmann
Sebastian Gießelmann
JDJoseph P. Dewulf
Joseph P. Dewulf
EWElsa Wiame
Elsa Wiame
AHAnja Holz
Anja Holz
FKFlorian Kraft
Florian Kraft
BACKGROUND. Deciphering the function of the many genes previously classified as uncharacterized open reading frame (ORF) would complete our understanding of a cell’s function and its pathophysiology. METHODS. Whole-exome sequencing, yeast 2-hybrid and transcriptome analyses, and molecular characterization were performed in this study to uncover the function of the C2orf69 gene. RESULTS. We identified loss-of-function mutations in the uncharacterized C2orf69 gene in 8 individuals with brain abnormalities involving hypomyelination and microcephaly, liver dysfunction, and recurrent autoinflammation. C2orf69 contains an N-terminal signal peptide that is required and sufficient for mitochondrial localization. Consistent with mitochondrial dysfunction, the patients showed signs of respiratory chain defects, and a CRISPR/Cas9-KO cell model of C2orf69 had similar respiratory chain defects. Patient-derived cells revealed alterations in immunological signaling pathways. Deposits of periodic acid–Schiff–positive (PAS-positive) material in tissues from affected individuals, together with decreased glycogen branching enzyme 1 (GBE1) activity, indicated an additional impact of C2orf69 on glycogen metabolism. CONCLUSIONS. Our study identifies C2orf69 as an important regulator of human mitochondrial function and suggests that this gene has additional influence on other metabolic pathways.